Home
Foley & Lardner
Antoinette F. Konski
Antoinette F. Konski
Foley & Lardner
White House Report Identifies Precision Medicine For Future R & D Investment
18 Apr 2023 | United States
Personalized Medicine At FDA: The Scope & Significance Of Progress In 2022
22 Mar 2023 | United States
USPTO Extends Patents 4 Patients Program
05 Oct 2022 | United States
Impact Of Current 101 Jurisprudence On Precision Medicine Innovation
08 Jul 2022 | United States
Personalized Medicine: 2021 FDA Guideposts For Progress – Focus On Diagnostics
15 Mar 2022 | United States
Personalized Medicine: 2021 FDA Guideposts For Progress
04 Mar 2022 | United States
Can AI Transform Precision Medicine?
05 Nov 2020 | United States
Episode 12: Personalized Medicine, The Health Care Of The Future
28 Aug 2020 | United States
Does Payer Coverage Drive Genomic Test Utilization In The United States?
27 Aug 2020 | United States
Coronavirus Innovation Guideposts On The Eve Of The COVID-19 Pandemic
03 Aug 2020 | United States
All Of Us Research Workbench Open For User Feedback
09 Jul 2020 | United States
Adjusting To Alice: USPTO's View Of Its Examination Guidelines
21 May 2020 | United States
Improving 21st Century Cures Act: Personalized Medicine And COVID-19
18 May 2020 | United States
Personalized Medicine Coalition Releases Spring 2020 Newsletter Amid COVID-19
29 Apr 2020 | United States
Utilization Of Natural Phenomenon Found Patent Eligible
20 Apr 2020 | United States
Collaborative Review Of Scientific Evidence Announced By FDA
16 Mar 2020 | United States
2019 FDA Precision Medicine Approvals: Progress At FDA
26 Feb 2020 | United States
2020 Business Of Personalized Medicine Summit: Break Through To Solutions In The Birthplace Of Biotechnology
24 Feb 2020 | United States
USPTO Updates Guidance On Patent-Eligibility Of Personalized Therapy
21 Nov 2019 | United States
Personalized Cancer Therapy Found Nonobvious
28 Oct 2019 | United States
< 1 2 3 4 5 6 7 8 9 10 >
Contact Details
Chicago
321 North Clark Street, Suite 2800
Chicago IL 60654-5313
United States
Telephone: 1-312-8324734

  © Mondaq® Ltd 1994 - 2023. All Rights Reserved.